Recursion Pharmaceuticals, Inc.
RXRX · Healthcare · $2.2B
Pre-market $4.14+0.24%
Price
$3.80
$4.03
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue$8M+18.5%
Operating Income-$135M-5.0%
Net Income-$131M-11.5%
3/'26 vs prev quarter
Company Health
Market Cap$2.2B
Operating Margin-991.7%
Cash on Hand$546M25.2% of market cap
Free Cash Flow$-434M-20.0% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR39.5xmedian 11.4xPBR2.4xmedian 2.0xROE-56.7%median -54.5%
